What's in Dr. Falk Pharma GmbH's pipeline?

Dr. Falk Pharma GmbH has 10 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 5 in Phase 2, 0 in Phase 1.

Which companies overlap with Dr. Falk Pharma GmbH's portfolio?

Top competitors by shared drug class: Bharat Serums and Vaccines Limited, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Drugs for Neglected Diseases, Federal University of Health Science of Porto Alegre.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dr-falk-pharma-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Dr. Falk Pharma GmbH — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dr. Falk Pharma GmbH pipeline: 2 marketed, 0 filed, 3 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 5 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
low dose budesonide tablet	low dose budesonide tablet	marketed
high dose budesonide tablet	high dose budesonide tablet	marketed
Placebo orodispersible tablet twice daily	Placebo orodispersible tablet twice daily	phase 3
mesalamine granules	mesalamine granules	phase 3	aminosalicylate		Gastroenterology
norUrsodeoxycholic acid	norUrsodeoxycholic acid	phase 3	FXR agonist	FXR	Liver disease

Therapeutic area mix

Gastroenterology · 1
Infectious Disease · 1
Liver disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bharat Serums and Vaccines Limited · 1 shared drug class
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 1 shared drug class
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · 1 shared drug class
Drugs for Neglected Diseases · 1 shared drug class
Federal University of Health Science of Porto Alegre · 1 shared drug class
Fundacion Nacional de Dermatologia · 1 shared drug class
Gannex Pharma Co., Ltd. · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Dr. Falk Pharma GmbH:

Cite this brief

Drug Landscape (2026). Dr. Falk Pharma GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dr-falk-pharma-gmbh. Accessed 2026-05-16.